leadership

Business leader who leads Max Healthcare, the Indian private hospital group whose network includes the Max Institute of Cancer Care.

Bern medical oncology chief whose lab targets leukaemia stem cells and CD70 signalling.

Hematologist who directs Kyoto University Hospital, one of Japan's leading academic medical centres.

Health manager who leads the IRCCS Istituto Tumori Giovanni Paolo II in Bari, first as Direttore Generale and, since 2025, as Commissario Straordinario.

Oncology pharmacist-scientist at UC Irvine and President of MASCC, the multinational society for supportive care in cancer, known for research on cancer-related cognitive impairment.

Lille pulmonologist and thoracic oncologist who presides over the IFCT, France's academic lung cancer trials group.

Thoracic oncologist who heads the Oncology Division at Geneva University Hospitals.

Physician who directs the Naef K. Basile Cancer Institute, the multidisciplinary cancer centre of the American University of Beirut Medical Center in Lebanon.

Materials scientist and biotechnology founder who directs ARPA-H, the United States agency that funds high-risk, high-reward health research programmes.

Neuroscientist who has been President of the Weizmann Institute of Science since 2019, leading one of the world's foremost basic research institutes, including its cancer research programmes.

Former head of NHS England who returned to lead Guy's and St Thomas' NHS Foundation Trust as Chief Executive in September 2025.

Medical oncologist from Gipuzkoa who became President of GEICAM, Spain's academic breast cancer research group, in 2025 on the retirement of its founder Miguel Martín.

Chief executive of the Canadian Cancer Society, the national charity that funds cancer research, advocates on policy and runs support services across Canada.

President of Fondazione AIRC, the Italian charitable foundation that raises funds from the public to finance cancer research across the country.

Chief Executive of Movember, the global men's health charity that funds prostate cancer, testicular cancer and mental health programmes.

Structural biologist who directs the Purdue Institute for Cancer Research, an NCI-designated basic science cancer centre in West Lafayette, Indiana.

Radiation oncologist specialising in head and neck cancer who oversees clinical affairs at Poland's National Research Institute of Oncology.

Oslo gynaecological oncology surgeon at the Norwegian Radium Hospital and President-Elect of ESGO.

Indian Administrative Service officer who, as Joint Secretary for PMSSY, heads the health ministry division that builds the new AIIMS hospitals and upgrades government medical colleges.

Pathologist and Scientific Director of the Candiolo Cancer Institute (INOC), Piedmont's oncology IRCCS and an OECI-certified Comprehensive Cancer Centre.

Health system executive who leads City of Hope Orange County and oversaw the opening of Orange County's first cancer specialty hospital in Irvine.

Chief physician who directs Tays Cancer Centre in Tampere and the FICAN Mid regional cancer centre for central Finland.

Head of Australia's medicines and medical devices regulator, the body that approves cancer drugs for the Australian market.

Former county council chief executive who has led Nottingham University Hospitals NHS Trust, which runs the Nottingham cancer centre at City Hospital, since September 2022.

Leading nasopharyngeal carcinoma researcher who directs the Hong Kong Cancer Institute at CUHK.

Ferrara haematologist and CLL expert who chairs GIMEMA's Scientific Committee.

Gynaecological medical oncologist directing the Cancer Center Clínica Universidad de Navarra; led the PRIMA trial of niraparib maintenance in ovarian cancer.

Physician who presides over the board of trustees of the Fundación Instituto Valenciano de Oncología (IVO), the private non profit cancer centre in Valencia.

Immunologist and Scientific Director of the Istituto Oncologico Veneto, leading its translational cancer research.

Veteran Italian medical oncologist who leads oncology and haematology at Humanitas and has co-authored major trials in lymphoma, liver cancer and novel targeted drugs.

Executive Director of ICESP, the São Paulo state cancer institute of the Hospital das Clínicas that treats public-system patients across four units.

Radiologist who leads the King Hussein Cancer Center in Amman, the leading comprehensive cancer centre in Jordan and the region.

Chief executive of CCLG, the UK charity and professional body that unites the children's and young people's cancer community.

Executive Director of the Tumour Centre at University Hospital Basel, coordinating the hospital's organ-specific cancer centres.

Professor who chairs the executive board of University Medical Center Groningen, the academic hospital in the northern Netherlands that houses the UMCG Comprehensive Cancer Center.

Physician who directs Ramathibodi Hospital, the university hospital of the Faculty of Medicine Ramathibodi Hospital at Mahidol University in Bangkok.

Cancer biologist who directs the Cancer Research UK Convergence Science Centre, the joint Institute of Cancer Research and Imperial College London programme bringing engineering and physical sciences into cancer research.

Milan radiation oncologist leading ESTRO, Europe's radiotherapy and oncology society.

Clinical oncologist who directs Poland's national cancer institute, the Maria Skłodowska-Curie National Research Institute of Oncology in Warsaw.

Blood cell molecular biologist who has led Sydney's Garvan Institute of Medical Research since 2023, sharpening its focus on genomics, immunology and cancer.

President of the Instituto Alexander Fleming, a private specialist cancer hospital in Buenos Aires that opened in 1994.

Physician who directs Chile's Instituto Nacional del Cáncer, the country's public national cancer institute.

Chair of the executive board of Radboud university medical centre in Nijmegen, the academic hospital that houses the Radboudumc Centre for Oncology.

Pharmacist-health economist serving as 2026-2027 President of ISPOR, the global society for health economics and outcomes research.

Physician who serves as Director of Christian Medical College, Vellore, the not-for-profit teaching hospital and medical school in Tamil Nadu, India.

Oncologist who leads the Barbara Ann Karmanos Cancer Institute in Detroit as President and CEO and chairs the Department of Oncology at Wayne State University.

Hospital Director and CEO of Sahlgrenska University Hospital in Gothenburg, one of northern Europe's largest university hospitals.

Epigenetics researcher who became CEO of Huntsman Cancer Institute at the University of Utah in September 2025.

Professor appointed by royal decree in 2026 as Director General of the Rabat-Salé-Kénitra territorial health group, which runs the Institut National d'Oncologie in Rabat.

Nonprofit executive who leads The V Foundation, a charity that raises money to fund cancer research across the United States.

Geneticist known for work on the genetic drivers of childhood brain cancer who became Director and CEO of QIMR Berghofer, a leading Australian medical research institute, in 2026.

Urologist who has served as President of Hospital de Clínicas de Porto Alegre, a leading Brazilian university hospital, since 2024.

Radiation therapist turned health executive who leads Cancer Care Alberta, the provincial cancer programme for Alberta, Canada.

Chief Executive of Leeds Teaching Hospitals NHS Trust, the NHS trust that runs the Leeds Cancer Centre at St James's University Hospital.

Cambridge haematologist and EHA President Elect whose laboratory studies how epigenetic regulators drive leukaemia and how they can be targeted.

Principal investigator of HARMONi-2, the trial where ivonescimab beat pembrolizumab head-to-head, and of the first EGFR-TKI phase 3 in Chinese patients.

Chief executive of the Welsh health trust that runs Velindre Cancer Centre, the specialist cancer hospital for south east Wales.

Health manager who chairs the board of IPO Lisboa, the Portuguese Oncology Institute in Lisbon, since the board took office in 2025.

Cancer epidemiologist who co-leads KWF, the Dutch Cancer Society, the Netherlands' largest charitable funder of cancer research.

Physician and hospital director of Skåne University Hospital, the university hospital serving southern Sweden and home to Lund's cancer services.